12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga·01/07/2026 17:05:53

Listen to the news

Gainers

Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock rose 61.4% to $0.11 during Wednesday's regular session.
Monte Rosa Therapeutics (NASDAQ:GLUE) shares rose 52.77% to $24.46. The market value of their outstanding shares is at $1.0 billion.
Innovative Eyewear (NASDAQ:LUCY) shares increased by 51.63% to $1.79. The company's market cap stands at $6.3 million.
Regencell Bioscience (NASDAQ:RGC) shares moved upwards by 38.05% to $45.6. The company's market cap stands at $16.3 billion.
Ventyx Biosciences (NASDAQ:VTYX) stock increased by 37.91% to $13.86. The market value of their outstanding shares is at $717.1 million.
NovaBay Pharmaceuticals (AMEX:NBY) stock rose 36.94% to $10.12. The market value of their outstanding shares is at $931.2 million.

Losers

ProPhase Labs (NASDAQ:PRPH) shares declined by 18.4% to $0.2 during Wednesday's regular session.
Cyclerion Therapeutics (NASDAQ:CYCN) shares declined by 14.88% to $1.66. The market value of their outstanding shares is at $7.4 million.
Curis (NASDAQ:CRIS) stock declined by 13.27% to $0.87. The market value of their outstanding shares is at $12.9 million.
Park Dental Partners (NASDAQ:PARK) stock declined by 9.11% to $13.08. The company's market cap stands at $58.8 million.
WORK Medical Tech Gr (NASDAQ:WOK) stock declined by 8.94% to $1.89.
Theriva Biologics (AMEX:TOVX) stock decreased by 8.91% to $0.22. The company's market cap stands at $8.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number :+852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email :service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation :marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English